Is there any role for neoadjuvant chemotherapy in renal leiomyosarcoma?
Very rare tumor with sparse literature
Answer from: Medical Oncologist at Academic Institution
Contributing factors in this decision would include size, feasibility of organ preservation, and patient's PS/organ function. The regimen with some activity would include the combination of doxorubicin and dacarbazine.
Sign in or Register to read more